Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-31 @ 1:21 AM
Study NCT ID:
NCT00044733
Status:
COMPLETED
Last Update Posted:
2006-05-18
First Post:
2002-09-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell Transplant
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-09
Completion Date Type:
None
First Submit Date:
2002-09-04
First Submit QC Date:
None
Study First Post Date:
2002-09-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2006-05-17
Last Update Post Date:
2006-05-18
Last Update Post Date Type:
ESTIMATED